IRIS
VERGARO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.457
EU - Europa 7.873
AS - Asia 4.150
SA - Sud America 840
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 14
Totale 24.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.947
RU - Federazione Russa 2.617
SG - Singapore 2.122
IT - Italia 1.827
GB - Regno Unito 1.105
CN - Cina 847
BR - Brasile 743
DE - Germania 704
HK - Hong Kong 443
CA - Canada 437
UA - Ucraina 418
VN - Vietnam 256
IE - Irlanda 245
FR - Francia 197
SE - Svezia 174
FI - Finlandia 156
DK - Danimarca 117
IN - India 84
NL - Olanda 72
TR - Turchia 67
AT - Austria 66
PL - Polonia 55
BD - Bangladesh 54
PK - Pakistan 46
MX - Messico 45
ES - Italia 35
ID - Indonesia 35
AR - Argentina 34
IQ - Iraq 33
ZA - Sudafrica 31
AE - Emirati Arabi Uniti 29
UZ - Uzbekistan 26
JP - Giappone 24
EU - Europa 21
LT - Lituania 19
BE - Belgio 12
MA - Marocco 12
RO - Romania 12
VE - Venezuela 12
CO - Colombia 11
SA - Arabia Saudita 9
UY - Uruguay 9
AZ - Azerbaigian 8
CH - Svizzera 8
CL - Cile 8
EC - Ecuador 8
MC - Monaco 8
PE - Perù 8
AU - Australia 7
CZ - Repubblica Ceca 7
IR - Iran 7
NZ - Nuova Zelanda 7
PH - Filippine 7
AM - Armenia 6
JO - Giordania 6
TH - Thailandia 5
CR - Costa Rica 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BB - Barbados 3
BO - Bolivia 3
HN - Honduras 3
KR - Corea 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
SM - San Marino 3
TN - Tunisia 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
LB - Libano 2
MY - Malesia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
Totale 24.412
Salva come PNG Salva come JPEG
Città #
Singapore 1.240
Chicago 1.156
Los Angeles 624
Beijing 618
Southend 540
Salt Lake City 511
Chandler 443
Fairfield 411
Hong Kong 402
Ashburn 375
San Mateo 329
Woodbridge 329
Tampa 293
Houston 290
Wilmington 276
Buffalo 271
Seattle 251
Moscow 250
Ann Arbor 243
Dublin 239
Cambridge 232
Falls Church 232
Elk Grove Village 220
The Dalles 204
Boardman 189
Jacksonville 183
Ottawa 182
Dearborn 162
Milan 156
Beauharnois 155
Portsmouth 153
Munich 141
Stevenage 141
Pisa 137
Dong Ket 115
Dallas 114
Sterling 111
Rome 109
Lawrence 106
Lancaster 103
New York 94
Santa Clara 89
Florence 84
London 69
Brooklyn 68
Miami 68
Dulles 65
São Paulo 65
Nuremberg 61
Frankfurt am Main 59
Helsinki 49
San Diego 47
Turku 47
Warsaw 44
Kansas City 43
Detroit 42
Fremont 39
Istanbul 39
Redwood City 36
Washington 35
Bologna 34
Lappeenranta 34
San Francisco 32
Padova 29
Phoenix 29
Genoa 28
Pittsburgh 28
Vienna 28
Belo Horizonte 27
Montréal 27
Mexico City 26
Bari 25
Lucca 25
Assago 24
Montreal 24
Palermo 24
Tashkent 24
Rio de Janeiro 23
Shanghai 23
Las Vegas 22
Livorno 22
Naples 21
New Delhi 21
Toronto 21
Turin 21
Atlanta 20
Central District 20
Düsseldorf 20
Johannesburg 20
Amsterdam 19
Boston 19
Guangzhou 19
Hangzhou 19
Charlotte 18
Hanoi 18
Paris 18
Tokyo 18
Old Bridge 17
Buti 15
Brescia 14
Totale 14.295
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.727
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.501
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.409
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 613
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 479
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 257
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 225
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 215
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 211
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 202
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 197
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 195
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 190
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 190
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 188
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 186
Update sui biomarcatori nello scompenso cardiaco. 180
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 180
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 178
A simple echocardiographic score to rule out cardiac amyloidosis 177
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 175
Cardiac light-chain deposition disease relapsing in the transplanted heart 175
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 172
Adrenergic activation in heart failure: blockade or rebalance? 171
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 170
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 167
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 165
Prognostic value of plasma Renin activity in heart failure. 164
Sex-related differences in chronic heart failure 164
Correction of procedural arterial pseudoaneurysms: Established and novel procedures 160
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 156
The search for efficient diagnostic and prognostic biomarkers of heart failure 156
How to take arms against central apneas in heart failure 154
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 152
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 147
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 146
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 141
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 138
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 138
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 136
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 135
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 132
A simple echocardiographic score to rule out cardiac amyloidosis 130
Screening the health status of people working in a university 129
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 128
Biomarkers for the diagnosis and management of heart failure 127
Heart, kidney and FGF23: Les liaisons dangereuses 125
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 125
Atrial amyloidosis: mechanisms and clinical manifestations 124
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure 122
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 122
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 120
Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records 118
Cheyne-Stokes respiration and heart failure: pathophysiologicaland clinical implications 117
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 116
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 116
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 115
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 114
Renin profiling predicts neurohormonal response to sacubitril/valsartan 114
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 113
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 112
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome 111
Cardiogenic shock and acute kidney injury: the rule rather than the exception 110
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 110
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 110
Eligibility for vericiguat in a real‐world, contemporary heart failure population 109
Role of Imaging in Cardiomyopathies 107
N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure 107
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 107
Management of complications of cardiac amyloidosis: 10 questions and answers 107
Subclinical cardiac damage in cancer patients before chemotherapy 106
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 105
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 105
Biomarkers for the diagnosis and management of heart failure: New frontiers 105
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 105
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 103
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction 102
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 102
Sex-related differences in chronic heart failure 102
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 102
Disease features and management of cardiomyopathies in women 101
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 101
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 101
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 101
Molecular autopsy of sudden cardiac death in the genomics era 99
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 98
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 98
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 98
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 97
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 96
Left ventricular ejection fraction for risk stratification in chronic systolic heart failure 96
Therapies for cardiac light chain amyloidosis: An update 96
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 95
Deep-learning-based cardiac amyloidosis classification from early acquired pet images 94
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images 92
Valvular heart disease in patients with cardiac amyloidosis 92
Quality of life and outcome in heart failure with preserved ejection fraction: When sex matters 92
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 92
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome 92
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 91
Totale 18.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.124 0 193 94 205 120 286 198 136 187 151 243 311
2021/20221.911 161 295 80 196 74 67 201 333 141 195 36 132
2022/20231.334 109 110 62 140 164 175 36 120 251 30 82 55
2023/20241.331 76 36 239 101 73 120 102 65 51 75 55 338
2024/202513.502 112 132 487 200 420 489 1.183 2.120 812 2.024 3.134 2.389
2025/20261.869 1.474 395 0 0 0 0 0 0 0 0 0 0
Totale 24.690